Investment Rating - The investment rating for the company is "Accumulate" (maintained) [7] Core Views - The company achieved a revenue of 840 million yuan in H1 2025, representing a year-on-year increase of 19.7%, and a net profit attributable to shareholders of 90 million yuan, up 17.6% year-on-year [1] - The online channel continues to drive growth, with e-commerce revenue reaching 300 million yuan in H1 2025, a significant increase of 86.9% year-on-year, while offline revenue remained stable at 540 million yuan, down 0.2% year-on-year [2] - The company is focusing on new product launches, particularly in the medical research category, which is expected to enhance growth and optimize product structure [4] - The company is the absolute leader in the sensitive toothpaste market, with strong growth potential through product upgrades and market expansion [5] Financial Performance Summary - In H1 2025, the gross margin was 52.6%, an increase of 5.7 percentage points year-on-year, while the net profit margin was 10.1%, a slight decrease of 0.18 percentage points year-on-year [3] - The company forecasts revenues of 1.863 billion yuan, 2.191 billion yuan, and 2.574 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 196 million yuan, 235 million yuan, and 282 million yuan [12]